NEUROCRINE BIOSCIENCES INC
NBIXNASDAQ🏆 #631 by market capEarnings Nov 2 · PostUS Equity
$145.53▼ $0.47 (−0.32%)
🌙 After hours$148.45▲ 2.01%Regular close · extended-hours price shownTrack NBIX
Get earnings, price moves & breaking news on Telegram
24h▼ 0.3%
7d▲ 1.6%
14d▲ 6.2%
30d▲ 5.2%
ytd▲ 2.7%
1y▲ 5.4%
🏦Market Cap
$14.79B
Mid Cap
📈Revenue Growth (YoY)
34.4%
High Growth
📊Gross Margin
98.0%
High
💵FCF Margin
25.8%
Strong
⚖️P/S Ratio
4.4x
Fair
Otter Score
84
Strong
NEUROCRINE BIOSCIENCES INC
NBIXAnalyst Ratings
Price
$145.53
Total
37
Raised
1
Lowered
0
Avg PT
$204.18
H / L
$230 / $165
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Needham | Reiterated | Buy | 2026-10-16 | $204.00 | +40.20% |
BMO Capital | Reiterated | Market Perform | 2026-10-12 | $170.00 | +16.80% |
UBS | Reiterated | Buy | 2026-09-29 | $214.00 | +47.00% |
Morgan Stanley | Reiterated | Equal Weight | 2026-09-11 | $183.00 | +25.70% |
RBC Capital | Reiterated | Outperform | 2026-09-08 | $198.00 | +36.10% |
Citigroup | Reiterated | Buy | 2026-09-03 | $129.00 | −11.40% |
Canaccord Genuity | Reiterated | Buy | 2026-08-03 | $210.00 | +44.30% |
Truist Securities | Reiterated | Buy | 2026-08-03 | — | — |
Wedbush | Reiterated | Outperform | 2026-08-03 | $194.00 | +33.30% |
Piper Sandler | Reiterated | Overweight | 2026-07-31 | $210.00 | +44.30% |
TD Cowen | Reiterated | Buy | 2026-07-31 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2026-07-31 | $195.00 | +34.00% |
Guggenheim | Reiterated | Buy | 2026-07-31 | $222.00 | +52.50% |
Stifel | Reiterated | Buy | 2026-07-31 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-07-17 | $200.00 | +37.40% |
JP Morgan | Reiterated | Overweight | 2026-05-08 | — | — |
Leerink Partners | Reiterated | Outperform | 2026-04-22 | $100.00 | −31.30% |
HC Wainwright & Co. | Reiterated | Buy | 2026-04-07 | — | — |
Mizuho | Reiterated | Neutral | 2025-12-12 | — | — |
Baird | Reiterated | Outperform | 2025-07-31 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2025-04-24 | — | — |
B of A Securities | Reiterated | Buy | 2025-02-07 | — | — |
Barclays | Reiterated | Overweight | 2024-12-23 | $160.00 | +9.90% |
Jefferies | Reiterated | Buy | 2024-08-19 | $174.00 | +19.60% |
Oppenheimer | Reiterated | Outperform | 2024-08-02 | $230.00 | +58.00% |
Goldman Sachs | Reiterated | Buy | 2024-01-25 | $213.00 | +46.40% |
Raymond James | Reiterated | Outperform | 2023-11-01 | $155.00 | +6.50% |
SVB Leerink | Reiterated | Market Perform | 2022-11-02 | — | — |
Credit Suisse | Reiterated | Neutral | 2020-11-10 | — | — |
Piper Jaffray | Reiterated | Overweight | 2019-07-30 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2018-09-20 | $188.00 | +29.20% |
Deutsche Bank | Reiterated | Buy | 2018-05-01 | $165.00 | +13.40% |
Bank of America | Reiterated | Buy | 2018-05-01 | — | — |
Leerink Swann | Reiterated | Outperform | 2017-11-02 | — | — |
PiperJaffray | Reiterated | Overweight | 2015-06-17 | — | — |
MKM Partners | Reiterated | Buy | 2014-11-04 | — | — |
Cowen & Co. | Upgraded | Market Perform → Outperform | 2013-08-21 | — | — |
Institution
Needham
Reiterated · Buy · 2026-10-16
$204.00
+40.20%
BMO Capital
Reiterated · Market Perform · 2026-10-12
$170.00
+16.80%
UBS
Reiterated · Buy · 2026-09-29
$214.00
+47.00%
Morgan Stanley
Reiterated · Equal Weight · 2026-09-11
$183.00
+25.70%
RBC Capital
Reiterated · Outperform · 2026-09-08
$198.00
+36.10%
Citigroup
Reiterated · Buy · 2026-09-03
$129.00
−11.40%
Canaccord Genuity
Reiterated · Buy · 2026-08-03
$210.00
+44.30%
Truist Securities
Reiterated · Buy · 2026-08-03
—
—
Wedbush
Reiterated · Outperform · 2026-08-03
$194.00
+33.30%
Piper Sandler
Reiterated · Overweight · 2026-07-31
$210.00
+44.30%
TD Cowen
Reiterated · Buy · 2026-07-31
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2026-07-31
$195.00
+34.00%
Guggenheim
Reiterated · Buy · 2026-07-31
$222.00
+52.50%
Stifel
Reiterated · Buy · 2026-07-31
—
—
Wells Fargo
Reiterated · Overweight · 2026-07-17
$200.00
+37.40%
JP Morgan
Reiterated · Overweight · 2026-05-08
—
—
Leerink Partners
Reiterated · Outperform · 2026-04-22
$100.00
−31.30%
HC Wainwright & Co.
Reiterated · Buy · 2026-04-07
—
—
Mizuho
Reiterated · Neutral · 2025-12-12
—
—
Baird
Reiterated · Outperform · 2025-07-31
—
—
Evercore ISI Group
Reiterated · Outperform · 2025-04-24
—
—
B of A Securities
Reiterated · Buy · 2025-02-07
—
—
Barclays
Reiterated · Overweight · 2024-12-23
$160.00
+9.90%
Jefferies
Reiterated · Buy · 2024-08-19
$174.00
+19.60%
Oppenheimer
Reiterated · Outperform · 2024-08-02
$230.00
+58.00%
Goldman Sachs
Reiterated · Buy · 2024-01-25
$213.00
+46.40%
Raymond James
Reiterated · Outperform · 2023-11-01
$155.00
+6.50%
SVB Leerink
Reiterated · Market Perform · 2022-11-02
—
—
Credit Suisse
Reiterated · Neutral · 2020-11-10
—
—
Piper Jaffray
Reiterated · Overweight · 2019-07-30
—
—
Stifel Nicolaus
Reiterated · Buy · 2018-09-20
$188.00
+29.20%
Deutsche Bank
Reiterated · Buy · 2018-05-01
$165.00
+13.40%
Bank of America
Reiterated · Buy · 2018-05-01
—
—
Leerink Swann
Reiterated · Outperform · 2017-11-02
—
—
PiperJaffray
Reiterated · Overweight · 2015-06-17
—
—
MKM Partners
Reiterated · Buy · 2014-11-04
—
—
Cowen & Co.
Upgraded · Market Perform → Outperform · 2013-08-21
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space